These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. From nano- to macro-scale: nanotechnology approaches for spatially controlled delivery of bioactive factors for bone and cartilage engineering. Santo VE; Gomes ME; Mano JF; Reis RL Nanomedicine (Lond); 2012 Jul; 7(7):1045-66. PubMed ID: 22846091 [TBL] [Abstract][Full Text] [Related]
4. Nano/Micro-Assisted Regenerative Medicine. Choi B; Lee SH Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30049973 [TBL] [Abstract][Full Text] [Related]
5. [The current status and future perspective of tissue engineering and regenerative medicine]. Yamato M Nihon Rinsho; 2011 Dec; 69(12):2098-101. PubMed ID: 22242304 [No Abstract] [Full Text] [Related]
6. Nano-regenerative medicine towards clinical outcome of stem cell and tissue engineering in humans. Arora P; Sindhu A; Dilbaghi N; Chaudhury A; Rajakumar G; Rahuman AA J Cell Mol Med; 2012 Sep; 16(9):1991-2000. PubMed ID: 22260258 [TBL] [Abstract][Full Text] [Related]
7. Nanotechnology and multipotent adult progenitor cells in Reparative Medicine: therapeutic perspectives. Mazzeo A; Santos EJC Einstein (Sao Paulo); 2018 Nov; 16(4):eRB4587. PubMed ID: 30517369 [TBL] [Abstract][Full Text] [Related]
8. From tissue engineering to regenerative medicine--the potential and the pitfalls. Schenke-Layland K Adv Drug Deliv Rev; 2011 Apr; 63(4-5):193-4. PubMed ID: 21515319 [No Abstract] [Full Text] [Related]
9. The LOEX perspective on the role of tissue engineering in regenerative medicine. Auger FA Biomed Mater Eng; 2006; 16(4 Suppl):S19-25. PubMed ID: 16823109 [No Abstract] [Full Text] [Related]
10. Challenges in tissue engineering and regenerative medicine product commercialization: building an industry. Hellman KB; Johnson PC; Bertram TA; Tawil B Tissue Eng Part A; 2011 Jan; 17(1-2):1-3. PubMed ID: 20726818 [No Abstract] [Full Text] [Related]
11. Advanced methods for tissue engineering and regenerative medicine. Vunjak-Novakovic G Methods; 2015 Aug; 84():1-2. PubMed ID: 26117581 [No Abstract] [Full Text] [Related]
12. In the Spotlight: Tissue and Molecular Engineering. Desai TA IEEE Rev Biomed Eng; 2008; 1():21-2. PubMed ID: 22274897 [TBL] [Abstract][Full Text] [Related]
14. Tissue therapeutics and regenerative medicine. Jayasinghe SN Drug Discov Today; 2014 Jun; 19(6):711-3. PubMed ID: 24735731 [No Abstract] [Full Text] [Related]
15. Therapeutic cell delivery for in situ regenerative medicine. Wang DA; Mahato RI Adv Drug Deliv Rev; 2010 Jun; 62(7-8):669-70. PubMed ID: 20420868 [No Abstract] [Full Text] [Related]
16. An interview with I V Yannas. Tracing one of the deepest roots of biomaterials in tissue engineering/regenerative medicine. Interview by Myron Spector. Yannas IV Biomed Mater; 2013 Aug; 8(4):040401. PubMed ID: 23715065 [No Abstract] [Full Text] [Related]
18. The first stem cell-based tissue-engineered organ replacement: implications for regenerative medicine and society. Hollander A; Macchiarini P; Gordijn B; Birchall M Regen Med; 2009 Mar; 4(2):147-8. PubMed ID: 19317632 [No Abstract] [Full Text] [Related]
19. The 4th China-France Biotherapy and Regenerative Medicine International Symposium 2011. Stoltz JF; Zhou YF; He XH; Chen Y Biomed Mater Eng; 2012; 22(1-3):1-2. PubMed ID: 22766696 [No Abstract] [Full Text] [Related]
20. In vitro human tissue models--moving towards personalized regenerative medicine. Schenke-Layland K; Nerem RM Adv Drug Deliv Rev; 2011 Apr; 63(4-5):195-6. PubMed ID: 21600252 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]